104 related articles for article (PubMed ID: 37121997)
1. TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Zorea J; Motro Y; Mazor RD; Carmi YK; Shulman Z; Mahajna J; Moran-Gilad J; Elkabets M
J Exp Clin Cancer Res; 2023 May; 42(1):107. PubMed ID: 37121997
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the immune landscapes of advanced ovarian cancer in an optimized in vivo model.
Pisano S; Lenna S; Healey GD; Izardi F; Meeks L; Jimenez YS; Velazquez OS; Gonzalez D; Conlan RS; Corradetti B
Clin Transl Med; 2021 Oct; 11(10):e551. PubMed ID: 34709744
[TBL] [Abstract][Full Text] [Related]
3. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages.
Song M; Yeku OO; Rafiq S; Purdon T; Dong X; Zhu L; Zhang T; Wang H; Yu Z; Mai J; Shen H; Nixon B; Li M; Brentjens RJ; Ma X
Nat Commun; 2020 Dec; 11(1):6298. PubMed ID: 33293516
[TBL] [Abstract][Full Text] [Related]
4. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.
Rodriguez GM; Yakubovich E; Murshed H; Maranda V; Galpin KJC; Cudmore A; Hanna AMR; Macdonald E; Ramesh S; Garson K; Vanderhyden BC
Front Immunol; 2023; 14():1295208. PubMed ID: 38235131
[TBL] [Abstract][Full Text] [Related]
5. The nutritional supplement taurine activates p53-dependent and independent tumor suppressor mechanisms in various cellular models of ovarian cancer.
Centeno D; Farsinejad S; Kochetkova E; Volpari T; Klupczynska-Gabryszak A; Kung D; Polotaye T; Hyde E; Greenberg M; Pavlovic T; Alshehri S; Sullivan W; Plewa S; Vakifahmetoglu-Norberg H; Monsma FJ; Muller PAJ; Matysiak J; Zaborowski M; DiFeo A; Andres-Martin L; Norberg E; Iwanicki M
bioRxiv; 2023 Aug; ():. PubMed ID: 36909636
[TBL] [Abstract][Full Text] [Related]
6. Profiling of cytokines in human epithelial ovarian cancer ascites.
Matte I; Lane D; Laplante C; Rancourt C; Piché A
Am J Cancer Res; 2012; 2(5):566-80. PubMed ID: 22957308
[TBL] [Abstract][Full Text] [Related]
7. Interleukine-10 in ovarian cancer.
Levin G; Gotlieb WH
Chin Clin Oncol; 2024 May; ():. PubMed ID: 38735685
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer
Hu X; Xu X; Zeng X; Jin R; Wang S; Jiang H; Tang Y; Chen G; Wei J; Chen T; Chen Q
Gut Microbes; 2023; 15(1):2221093. PubMed ID: 37282604
[TBL] [Abstract][Full Text] [Related]
9. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer.
Zheng X; Wang X; Cheng X; Liu Z; Yin Y; Li X; Huang Z; Wang Z; Guo W; Ginhoux F; Li Z; Zhang Z; Wang X
Nat Cancer; 2023 Aug; 4(8):1138-1156. PubMed ID: 37488416
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer.
Zheng Y; Li S; Tang H; Meng X; Zheng Q
Front Immunol; 2023; 14():1153990. PubMed ID: 37426654
[TBL] [Abstract][Full Text] [Related]
11. M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance.
Zheng N; Wang T; Luo Q; Liu Y; Yang J; Zhou Y; Xie G; Ma Y; Yuan X; Shen L
Oncoimmunology; 2023; 12(1):2210959. PubMed ID: 37197441
[TBL] [Abstract][Full Text] [Related]
12. MetaTiME integrates single-cell gene expression to characterize the meta-components of the tumor immune microenvironment.
Zhang Y; Xiang G; Jiang AY; Lynch A; Zeng Z; Wang C; Zhang W; Fan J; Kang J; Gu SS; Wan C; Zhang B; Liu XS; Brown M; Meyer CA
Nat Commun; 2023 May; 14(1):2634. PubMed ID: 37149682
[TBL] [Abstract][Full Text] [Related]
13. Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy.
Dong Y; Gao Q; Chen Y; Zhang Z; Du Y; Liu Y; Zhang G; Li S; Wang G; Chen X; Liu H; Han L; Ye Y
Nat Commun; 2023 May; 14(1):2540. PubMed ID: 37137884
[TBL] [Abstract][Full Text] [Related]
14. Oral Mucosa in Cancer Patients-Putting the Pieces Together: A Narrative Review and New Perspectives.
Reuss JM; Alonso-Gamo L; Garcia-Aranda M; Reuss D; Albi M; Albi B; Vilaboa D; Vilaboa B
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444405
[TBL] [Abstract][Full Text] [Related]
15. The role of microbiota in the pathophysiology of uterine fibroids - a systematic review.
Korczynska L; Zeber-Lubecka N; Zgliczynska M; Zarychta E; Zareba K; Wojtyla C; Dabrowska M; Ciebiera M
Front Cell Infect Microbiol; 2023; 13():1177366. PubMed ID: 37305407
[TBL] [Abstract][Full Text] [Related]
16. Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model.
Ranoa DRE; Sharma P; Schane CP; Lewis AN; Valdez E; Marada VVVR; Hager MV; Montgomery W; Wolf SP; Schreiber K; Schreiber H; Bailey K; Fan TM; Hergenrother PJ; Roy EJ; Kranz DM
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258040
[TBL] [Abstract][Full Text] [Related]
17. Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data.
Sambruni G; Macandog AD; Wirbel J; Cagnina D; Catozzi C; Dallavilla T; Borgo F; Fazio N; Fumagalli-Romario U; Petz WL; Manzo T; Ravenda SP; Zeller G; Nezi L; Schaefer MH
Genome Med; 2023 May; 15(1):32. PubMed ID: 37131219
[TBL] [Abstract][Full Text] [Related]
18. A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation.
Peng X; Huang X; Lulu TB; Jia W; Zhang S; Cohen L; Huang S; Fan J; Chen X; Liu S; Wang Y; Wang K; Isoyama S; Dan S; Wang F; Zhang Z; Elkabets M; Kong D
Mol Cancer; 2024 Mar; 23(1):54. PubMed ID: 38486218
[TBL] [Abstract][Full Text] [Related]
19. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.
Zhang H; Liu Y; Liu J; Chen J; Wang J; Hua H; Jiang Y
J Hematol Oncol; 2024 Jan; 17(1):5. PubMed ID: 38233872
[TBL] [Abstract][Full Text] [Related]
20. Loss of B1 and marginal zone B cells during ovarian cancer.
Maslanka J; Torres G; Londregan J; Goldman N; Silberman D; Somerville J; Riggs JE
Cell Immunol; 2024; 395-396():104788. PubMed ID: 38000306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
